SCHEMBL4385948

SCHEMBL4385948

COC(=O)Cc1c(C(C)=O)c(OC(=O)OC)cc(OC(=O)OC)c1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 1/20 0.40
HK2 P52789 1/20 0.39
ALDH1A1 P00352 3/20 0.36
CYP1A2 P05177 1/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SLC7A5 Q01650 1/20 0.36
EGFR P00533 2/20 0.36
NPC1 O15118 1/20 0.36
PKM P14618 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4392454 0.88 ADORA3 (0.40) KDM4EHPGDHSD17B10ALDH1A1THRB
SCHEMBL4388439 0.82 EGFR (0.41) KDM4EHPGDHK2ALDH1A1CYP1A2
SCHEMBL4380774 0.82 HPGD (0.39) KDM4EHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL4394063 0.77 L3MBTL1 (0.43) KDM4EHPGDHK2ALDH1A1CYP1A2
SCHEMBL4385012 0.75 L3MBTL1 (0.39) KDM4EHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL4389156 0.73 EGFR (0.46) KDM4EHPGDALDH1A1CYP1A2THRB
SCHEMBL4381890 0.72 TSHR (0.40) KDM4EHPGDHSD17B10ALDH1A1THRB
SCHEMBL4380813 0.71 TSHR (0.41) ALDH1A1THRBNPC1RAB9ASMN1; SMN2
SCHEMBL4385993 0.70 L3MBTL1 (0.48) KDM4EHPGDALDH1A1CYP1A2THRB
SCHEMBL4390345 0.68 EGFR (0.43) KDM4EHPGDALDH1A1CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P KDM4E 3223/4885HPGD 3238/4885HSD17B10 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.